These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 17725441)

  • 1. A patient with asymmetric parotid uptake on a diagnostic iodine-131 scan during thyroid cancer follow-up.
    Frew J; Mallick U; Perros P
    Thyroid; 2007 Aug; 17(8):801-2. PubMed ID: 17725441
    [No Abstract]   [Full Text] [Related]  

  • 2. Stunning with 131I diagnostic whole-body imaging of patients with thyroid cancer.
    Gerard SK; Dam HQ
    Radiology; 2005 Mar; 234(3):972-3; author reply 973-4. PubMed ID: 15734947
    [No Abstract]   [Full Text] [Related]  

  • 3. Coregistered iodine-131 single photon emission computed tomography/computed tomography reveals dedifferentiation in a metastatic follicular thyroid carcinoma.
    Walter MA; Wild D; Rasch H; Müller-Brand J; Müller B; Bilz S
    Thyroid; 2006 Oct; 16(10):1063-4. PubMed ID: 17042695
    [No Abstract]   [Full Text] [Related]  

  • 4. [Parotid gland function following radioiodine therapy of thyroid cancer based on data from radionuclide sialoscintigraphy].
    Sorokin IN; Prikhod'ko AG
    Stomatologiia (Mosk); 1987; 66(2):50-2. PubMed ID: 3033850
    [No Abstract]   [Full Text] [Related]  

  • 5. Self-stunning in thyroid ablation: evidence from comparative studies of diagnostic 131I and 123I.
    Hilditch TE; Dempsey MF; Bolster AA; McMenemin RM; Reed NS
    Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):783-8. PubMed ID: 12029552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dramatic parotid uptake of I-131 on a diagnostic whole-body scan.
    Carlisle MR; McDougall IR
    Clin Nucl Med; 2000 Nov; 25(11):895-7. PubMed ID: 11079586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 131I therapeutic efficacy is not influenced by stunning after diagnostic whole-body scanning.
    Dam HQ; Kim SM; Lin HC; Intenzo CM
    Radiology; 2004 Aug; 232(2):527-33. PubMed ID: 15286323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metastatic parotid tumor: a rare presentation for papillary carcinoma of thyroid.
    Malhotra G; Nair N; Awasare S; Baghel NS
    Clin Nucl Med; 2007 Jun; 32(6):488-90. PubMed ID: 17515766
    [No Abstract]   [Full Text] [Related]  

  • 9. Quantitative radioiodine therapy in the treatment of differentiated thyroid cancer.
    Maxon HR
    Q J Nucl Med; 1999 Dec; 43(4):313-23. PubMed ID: 10731782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of diagnostic radioiodines on the uptake of ablative dose of iodine-131.
    Park HM; Perkins OW; Edmondson JW; Schnute RB; Manatunga A
    Thyroid; 1994; 4(1):49-54. PubMed ID: 8054861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased uptake of therapeutic doses of iodine-131 after 185-MBq iodine-131 diagnostic imaging for thyroid remnants in differentiated thyroid carcinoma.
    Leger FA; Izembart M; Dagousset F; Barritault L; Baillet G; Chevalier A; Clerc J
    Eur J Nucl Med; 1998 Mar; 25(3):242-6. PubMed ID: 9580856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parotid gland involvement as an initial presentation of papillary thyroid carcinoma.
    Kilic K; Sakat MS; Gozeler MS; Demirci E
    Int J Oral Maxillofac Surg; 2017 Aug; 46(8):965-967. PubMed ID: 28442208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 99mTc-MIBI in differentiated thyroid carcinoma.
    Roelants V; Beckers C
    J Nucl Med; 1999 Oct; 40(10):1769. PubMed ID: 10520721
    [No Abstract]   [Full Text] [Related]  

  • 14. Discordance of sialography and scintigraphy in unilateral chronic sialadenitis.
    Ilgan S; Ataç K; Oztürk E; Pabusçu Y; Bayhan H
    Nuklearmedizin; 1998; 37(6):218-20. PubMed ID: 9770717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of scanning doses of iodine-131 on subsequent first ablative treatment outcome in patients operated on for differentiated thyroid carcinoma.
    Muratet JP; Daver A; Minier JF; Larra F
    J Nucl Med; 1998 Sep; 39(9):1546-50. PubMed ID: 9744340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucoepidermoid Parotid Gland Tumor Found on Follow-up Radioiodine Scan for Differentiated Papillary Thyroid Cancer.
    Naik C; Basu S
    J Nucl Med Technol; 2017 Jun; 45(2):116-118. PubMed ID: 28408701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of radioactive iodine in patients with papillary and follicular thyroid cancer.
    Wartofsky L; Sherman SI; Gopal J; Schlumberger M; Hay ID
    J Clin Endocrinol Metab; 1998 Dec; 83(12):4195-203. PubMed ID: 9851751
    [No Abstract]   [Full Text] [Related]  

  • 18. [Thyroid cancer: metabolic treatment and follow-up using thyroglobulin levels and I-131 gammagraphy].
    Lampreave JL; Trampal C; Domínguez P; Bittini A
    Rev Clin Esp; 1998 May; 198(5):307-15. PubMed ID: 9658914
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of low-dose iodine-131 ablation of post-operative thyroid remnants: a study of 69 cases.
    Leung SF; Law MW; Ho SK
    Br J Radiol; 1992 Oct; 65(778):905-9. PubMed ID: 1422665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unusual intratracheal metastasis of differentiated thyroid cancer accurately depicted by SPECT/CT acquisition after radioiodine ablation.
    Aide N; Lehembre E; Gervais R; Bardet S
    Thyroid; 2007 Dec; 17(12):1305-6. PubMed ID: 17949266
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.